Intrinsiqq
CTT Pharmaceutical Holdings Inc. logo

CTT Pharmaceutical Holdings Inc. Insider Trading

CTTH

Compare
Last 12 months

Insiders bought 6K on the open market and sold nothing.

Net open-market
+6K
18 buys · 0 sales
Under a 10b5-1 plan
—
no sales
Insiders who bought / sold
1 / 0
executives and directors
Last open-market buy
Nov 2026
Nov 12, 2026

Get an email when CTTH's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Nov 12
    CTT Pharmaceutical Holdings, Inc.
    CEO · bought 1,500 at $0.05
    $81
    <0.1% of stake
  • Nov 4
    CTT Pharmaceutical Holdings, Inc.
    CEO · bought 9,000 at $0.05
    $450
    <0.1% of stake
  • Oct 26
    CTT Pharmaceutical Holdings, Inc.
    CEO · bought 5,880 at $0.06
    $335
    <0.1% of stake
  • Oct 15
    CTT Pharmaceutical Holdings, Inc.
    CEO · bought 2,000 at $0.06
    $114
    <0.1% of stake
  • Oct 6
    CTT Pharmaceutical Holdings, Inc.
    CEO · bought 3,700 at $0.06
    $204
    <0.1% of stake
  • Sep 28
    CTT Pharmaceutical Holdings, Inc.
    CEO · bought 3,400 at $0.06
    $204
    <0.1% of stake
  • Sep 22
    CTT Pharmaceutical Holdings, Inc.
    CEO · bought 10,100 at $0.05
    $505
    0.1% of stake
  • Sep 16
    CTT Pharmaceutical Holdings, Inc.
    CEO · bought 10,900 at $0.05
    $545
    0.1% of stake
  • Sep 10
    CTT Pharmaceutical Holdings, Inc.
    CEO · bought 3,500 at $0.05
    $175
    <0.1% of stake
  • Sep 4
    CTT Pharmaceutical Holdings, Inc.
    CEO · bought 9,800 at $0.05
    $490
    0.1% of stake
  • Sep 2
    CTT Pharmaceutical Holdings, Inc.
    CEO · bought 3,000 at $0.05
    $150
    <0.1% of stake
  • Aug 31
    CTT Pharmaceutical Holdings, Inc.
    CEO · bought 3,500 at $0.05
    $175
    <0.1% of stake
  • Aug 24
    CTT Pharmaceutical Holdings, Inc.
    CEO · bought 2,100 at $0.06
    $126
    <0.1% of stake
  • Aug 20
    CTT Pharmaceutical Holdings, Inc.
    CEO · bought 11,500 at $0.05
    $575
    0.1% of stake
  • Aug 19
    CTT Pharmaceutical Holdings, Inc.
    CEO · bought 10,000 at $0.06
    $600
    0.1% of stake
  • Aug 14
    CTT Pharmaceutical Holdings, Inc.
    CEO · bought 1,800 at $0.06
    $108
    <0.1% of stake
  • Aug 7
    CTT Pharmaceutical Holdings, Inc.
    CEO · bought 7,700 at $0.07
    $539
    <0.1% of stake
  • Dec 17, 2025
    CTT Pharmaceutical Holdings, Inc.
    CEO · bought 8,300 at $0.06
    $498
    0.1% of stake
  • Nov 20, 2025
    CTT Pharmaceutical Holdings, Inc.
    Large holder · bought 200,000 at $0.04
    8K
    5.7% of stake
  • Nov 20, 2025
    CTT Pharmaceutical Holdings, Inc.
    CEO · bought 62,900 at $0.04
    3K
    0.8% of stake
  • Oct 31, 2025
    CTT Pharmaceutical Holdings, Inc.
    CEO · bought 7,000 at $0.06
    $420
    <0.1% of stake
  • Sep 23, 2025
    CTT Pharmaceutical Holdings, Inc.
    CEO · bought 6,815 at $0.06
    $409
    <0.1% of stake
  • Aug 2, 2025
    CTT Pharmaceutical Holdings, Inc.
    CEO · bought 44,085 at $0.05
    2K
    0.6% of stake
  • Aug 1, 2025
    CTT Pharmaceutical Holdings, Inc.
    CEO · bought 15,800 at $0.04
    $632
    0.2% of stake
  • Jul 8, 2025
    CTT Pharmaceutical Holdings, Inc.
    CEO · bought 8,000 at $0.03
    $240
    0.1% of stake
  • Jun 26, 2025
    CTT Pharmaceutical Holdings, Inc.
    CEO · bought 39,600 at $0.03
    1K
    0.6% of stake
  • Jun 23, 2025
    CTT Pharmaceutical Holdings, Inc.
    CEO · bought 16,100 at $0.03
    $483
    0.2% of stake
  • Jun 9, 2025
    CTT Pharmaceutical Holdings, Inc.
    CEO · bought 82,158 at $0.05
    4K
    1.2% of stake
  • Apr 9, 2025
    CTT Pharmaceutical Holdings, Inc.
    CEO · bought 9,984 at $0.07
    $699
    0.2% of stake
  • Mar 31, 2025
    CTT Pharmaceutical Holdings, Inc.
    CEO · bought 15,510 at $0.05
    $776
    0.2% of stake
  • Mar 11, 2025
    CTT Pharmaceutical Holdings, Inc.
    CEO · bought 5,400 at $0.06
    $324
    <0.1% of stake
  • Mar 7, 2025
    CTT Pharmaceutical Holdings, Inc.
    CEO · bought 11,950 at $0.09
    1K
    0.2% of stake
  • Feb 5, 2025
    CTT Pharmaceutical Holdings, Inc.
    CEO · bought 5,200 at $0.12
    $624
    <0.1% of stake
  • Nov 25, 2024
    CTT Pharmaceutical Holdings, Inc.
    CEO · bought 23,346 at $0.06
    1K
    0.4% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch CTTH, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with CTTH

CompareIntrinsic value
ENTAEnanta Pharmaceuticals Inc.
$7.62-4.51%25
BDPTBioadaptives Inc.
$0.00-4.00%25
SKVISkinvisible Inc.
$0.18+0.00%0
PMHSPolomar Health Services Inc.
$0.15+45.00%30
TCRTAlaunos Therapeutics Inc.
$1.66+4.40%10
PULMPulmatrix Inc.
$1.28-10.21%40
OTLCOncotelic Therapeutics Inc.
$0.01+22.00%10
GTBPGT Biopharma, Inc.
$2.96-6.92%20

Spot a number that looks wrong? Check it in CTTH's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing CTTH

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.